4-butyrolactone has been researched along with uric acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanson, PD; Hazewinkel, HA; Pollmeier, M; Theyse, LF; van den Brom, WE | 1 |
| Drag, M; Hanson, PD; Kunkle, BN; Romano, D | 1 |
| Al-Nadaf, S; Budsberg, SC; Cathcart, CJ; Johnston, SA; Reynolds, LR | 1 |
| Álvarez, AI; Espín, JC; García-Villalba, R; González-Lobato, L; Merino, G; Miguel, V; Otero, JA; Prieto, JG | 1 |
| Bing, W; Di, Y; Han, Q; Hua, L; Qi-Ming, F; Shi-He, L; Shih-Mo, Y; Ting-Ting, T; Xiu-Guo, H; Yu-Gang, W; Yu-Hua, Z | 1 |
| Beugnet, F; de Salazar Alcalá, AG; Dehman, A; Gioda, L | 1 |
4 trial(s) available for 4-butyrolactone and uric acid
| Article | Year |
|---|---|
Comparison of the effects of firocoxib, carprofen and vedaprofen in a sodium urate crystal induced synovitis model of arthritis in dogs.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Carbazoles; Cross-Over Studies; Dog Diseases; Dogs; Female; Lameness, Animal; Male; Naphthalenes; Propionates; Sulfones; Synovitis; Time Factors; Uric Acid | 2008 |
Firocoxib efficacy preventing urate-induced synovitis, pain, and inflammation in dogs.
Topics: 4-Butyrolactone; Animals; Carbazoles; Cyclooxygenase 2 Inhibitors; Dog Diseases; Dogs; Female; Lameness, Animal; Male; Meloxicam; Severity of Illness Index; Sulfonamides; Sulfones; Synovitis; Thiazines; Thiazoles; Treatment Outcome; Uric Acid | 2007 |
Efficacy of ABT-116, an antagonist of transient receptor potential vanilloid type 1, in providing analgesia for dogs with chemically induced synovitis.
Topics: 4-Butyrolactone; Analgesia; Animals; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Indazoles; Injections, Intra-Articular; Lameness, Animal; Male; Phenylurea Compounds; Stifle; Sulfones; Synovitis; TRPV Cation Channels; Uric Acid | 2012 |
Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Dog Diseases; Dogs; Lameness, Animal; Random Allocation; Sulfones; Sulfonylurea Compounds; Uric Acid | 2019 |
2 other study(ies) available for 4-butyrolactone and uric acid
| Article | Year |
|---|---|
Effect of bovine ABCG2 polymorphism Y581S SNP on secretion into milk of enterolactone, riboflavin and uric acid.
Topics: 4-Butyrolactone; Animals; ATP-Binding Cassette Transporters; Biological Transport; Butylene Glycols; Cattle; Dogs; Female; Lactation; Lignans; Madin Darby Canine Kidney Cells; Milk; Mitoxantrone; Polymorphism, Single Nucleotide; Riboflavin; Uric Acid | 2016 |
Kinsenoside screening with a microfluidic chip attenuates gouty arthritis through inactivating NF-κB signaling in macrophages and protecting endothelial cells.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents; Arthritis, Gouty; Crystallization; Culture Media, Conditioned; Cyclooxygenase 2; Cytokines; Cytoprotection; Drug Evaluation, Preclinical; Extremities; Human Umbilical Vein Endothelial Cells; Inflammasomes; Inflammation Mediators; Lipopolysaccharide Receptors; Macrophages; Male; Mice; Microfluidics; Mitogen-Activated Protein Kinases; Monosaccharides; NF-kappa B; Rats, Sprague-Dawley; RAW 264.7 Cells; Signal Transduction; Uric Acid | 2016 |